Hillmann A G, Harmon S, Park S D E, O'brien J, Shields D C, Kenny D
Regenerative Medicine Institute, National University of Ireland, Galway, Ireland.
J Thromb Haemost. 2006 Feb;4(2):349-56. doi: 10.1111/j.1538-7836.2006.01684.x.
Comparisons of platelet RNAs could provide crucial information on platelet function, thrombopoiesis and the etiology of megakaryocyte (MK) or platelet disorders.
We developed a method for stringent purification of platelets from small blood samples from single donors. Purity of the platelet preparations was verified by an RT-PCR assay. We tested three methods to identify the differences in RNA between platelet sources.
Differential hybridization to cDNA macro-arrays and suppressive-subtractive hybridization PCR (SSH-PCR) were used to compare RNAs from normal platelets to those from a Bernard-Soulier syndrome (BSS) patient. Affymetrix GeneChip U133 plus 2.0 arrays were used to compare male and female platelet RNAs.
Macroarrays identified approximately 7500 platelet transcripts, but failed to identify differentially expressed transcripts with confidence. SSH-PCR produced libraries almost exclusively of mitochondrial-derived transcripts, but included nuclear-encoded genes that could not be confirmed by immunoblotting of normal and BSS platelet lysates. The Affymetrix platform gave reproducible profiles from our small-scale purified platelet preparations, whereas a partially purified platelet preparation produced a drastically skewed transcript profile. The microarray analysis identified the heparanase precursor transcript as overexpressed in female platelets, and we observed variable yet consistently higher levels of heparanase protein in female platelets compared with male platelets in four independent donor pairs.
This demonstrates for the first time that differential platelet transcript levels can identify changes in expression level of platelet proteins. Combined with our small-scale platelet preparation method, this establishes a system to compare platelets from the limited clinical sources to help elucidate molecular bases for platelet or megakaryocyte pathologies.
血小板RNA的比较可为血小板功能、血小板生成以及巨核细胞(MK)或血小板疾病的病因提供关键信息。
我们开发了一种从单供体的少量血样中严格纯化血小板的方法。通过逆转录聚合酶链反应(RT-PCR)检测验证血小板制剂的纯度。我们测试了三种方法来鉴定不同血小板来源之间RNA的差异。
利用与cDNA宏阵列的差异杂交和抑制性消减杂交PCR(SSH-PCR)比较正常血小板与伯纳德-索利尔综合征(BSS)患者血小板的RNA。使用Affymetrix GeneChip U133 plus 2.0芯片比较男性和女性血小板RNA。
宏阵列鉴定出约7500个血小板转录本,但未能可靠地鉴定出差异表达的转录本。SSH-PCR产生的文库几乎完全是线粒体来源的转录本,但包含一些核编码基因,这些基因无法通过正常和BSS血小板裂解物的免疫印迹得到证实。Affymetrix平台从我们小规模纯化的血小板制剂中给出了可重复的图谱,而部分纯化的血小板制剂产生了严重偏斜的转录图谱。微阵列分析确定乙酰肝素酶前体转录本在女性血小板中过表达,并且我们在四对独立供体中观察到,与男性血小板相比,女性血小板中乙酰肝素酶蛋白水平可变但始终较高。
这首次证明不同的血小板转录水平可识别血小板蛋白表达水平的变化。结合我们的小规模血小板制备方法,这建立了一个系统,用于比较有限临床来源的血小板,以帮助阐明血小板或巨核细胞病理学的分子基础。